British High Commission in Singapore Opens Science and Tech Office at research hub Biopolis

Singapore Life-Sciences Company Opens Research and Production Facility

01-Dec-2004

The British High Commission opened a new Science and Technology Office at the Biopolis. While the high commission has more than 20 science and technology offices around the world, its unit at Biopolis' Helios building is the first to be located in a research hub. The British High Commission is setting up shop at research hub Biopolis so it can be a science matchmaker for Singapore and Britain. International patent firm Lloyd Wise recently set up an office while Switzerland has set up its 'scientific embassy', Swiss House. On the same day too, pharmaceutical giant GlaxoSmithKline opened its research facility at Biopolis. A total of $62 million will be pumped into finding a cure for memory-related conditions such as Alzheimer's.

In addition, one of Singapore's first home-grown life-science companies is opening a multi-million-dollar research and production facility here. It also has ambitious plans to go regional with a cream for osteoarthritis and joint-injury sufferers. Lynk Biotechnologies' facility costs several million dollars and includes top-of-the-line proteomics equipment to sieve through various molecules - which are potential drugs - that switch on, or off, the functions of cells in the body. There are also animal-testing facilities and a semi-automated plant to produce the joint cream. Lynk's subsidiary, MediLynk, uses so-called transdermal technology to deliver drugs through the skin.

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Last viewed contents

The first ant methylomes uncover the relationship between DNA methylation and caste differentiation

EKF Diagnostics acquires Selah Genomics and DiaSpect Medical AB

Oncolytics Biotech Inc. Research Collaborators Demonstrate Reovirus/Gemcitabine Combination Has Synergistic Effect

Kiel Möbius Prize goes to renowned American microbiome researcher

Kiel Möbius Prize goes to renowned American microbiome researcher

Innovative Roche cancer medicine Avastin approved in EU - First Treatment of its Kind With Proven Survival Benefit for Patients With Advanced Colorectal Cancer

Eindhoven University of Technology opens new incubator facility for breakthrough research - Institute for Complex Molecular Systems gets new accommodation in an architecturally and historically special building

Eindhoven University of Technology opens new incubator facility for breakthrough research - Institute for Complex Molecular Systems gets new accommodation in an architecturally and historically special building

Midatech secures exclusive position to exploit magnetic noble metal nanoparticles through new IP licenses - Technology has potential applications in bacterial infection and cancer

Cresset Announces New International Sales Team

Innogenetics moves into human papillomavirus (HPV) diagnostics in line with its growth strategy

SpectruMedix and Transgenomic Enter into Distribution Agreement in Europe - Complementary Genetic Analysis Platform Adds Depth to Transgenomic's Product Portfolio

Dot Products: Analytical Applications of Enzymatic Growth of Quantum Dots

Codexis and Bristol-Myers Squibb extend the term of research agreement - Codexis Achieves Milestone